The expression file is data/realbenchmark/12.txt
The interested output is: 
p70S6K
List of all species:
{'pertuzumab', 'PKCa', 'HRG', 'AKT', 'trastuzumab', 'erlotinib', 'EGF', 'PDK1', 'p70S6K', 'ERBB3', 'ERBB1', 'mTOR', 'ERBB2', 'ERK1_2', 'MEK1_2', 'PLCg'}
-----Input names-----
{'trastuzumab', 'pertuzumab', 'HRG', 'erlotinib', 'EGF'}
----Intermediate nodes-----
{'PKCa', 'AKT', 'PDK1', 'ERBB3', 'ERBB1', 'mTOR', 'ERBB2', 'ERK1_2', 'MEK1_2', 'PLCg', 'p70S6K'}
Now arrange layout of the original network for visualization
INPUT NAMES LIST:
['EGF', 'HRG', 'erlotinib', 'pertuzumab', 'trastuzumab']
Sorted input names
['EGF', 'HRG', 'erlotinib', 'pertuzumab', 'trastuzumab']
There are 5 inputs with the range of input: 0 31
Sorted internames:
['AKT', 'ERBB1', 'ERBB2', 'ERBB3', 'ERK1_2', 'MEK1_2', 'PDK1', 'PKCa', 'PLCg', 'mTOR', 'p70S6K']
There are 11 intermediate nodes with the range of inter: 0 2047
----Generate table from output----
======Time for SIMULATING ORIGINAL NETWORK : 0.021429061889648438 seconds===
----Input knockout shapley value-----
('trastuzumab', 0.0)
('pertuzumab', -0.7)
('HRG', 0.3)
('erlotinib', -0.7)
('EGF', 0.3)
----Input knockIN shapley value-----
('trastuzumab', 0.0)
('pertuzumab', 0.8)
('HRG', -1.2)
('erlotinib', 0.8)
('EGF', -1.2)
-------Now perform the knockout procedure to original network-------
Knockout PKCa
Knockout AKT
Knockout PDK1
Knockout ERBB3
Knockout ERBB1
Knockout mTOR
Knockout ERBB2
Knockout ERK1_2
Knockout MEK1_2
Knockout PLCg
----KNOCKOUT VALUE for output p70S6K----
{'AKT': 0.0, 'ERBB1': 0.3, 'ERBB2': 0.0, 'ERBB3': 0.3, 'ERK1_2': 0.0, 'MEK1_2': 0.0, 'PDK1': 0.0, 'PKCa': 0.0, 'PLCg': 0.0, 'mTOR': 0.0}


-------Now perform the KNOCKIN procedure to intermediate nodes-------
Knockin PKCa
Knockin AKT
Knockin PDK1
Knockin ERBB3
Knockin ERBB1
Knockin mTOR
Knockin ERBB2
Knockin ERK1_2
Knockin MEK1_2
Knockin PLCg
----KNOCKIN VALUE for output p70S6K----
{'AKT': -5.2, 'ERBB1': -5.2, 'ERBB2': -5.2, 'ERBB3': -5.2, 'ERK1_2': -5.2, 'MEK1_2': -5.2, 'PDK1': -5.2, 'PKCa': 0.0, 'PLCg': -1.2, 'mTOR': -5.2}


original.html
----------WITH ACYCLIC FLAG-------------
-------------Now convert the acyclic network to the binary network---------------


-------WORKING WITH BINARY NETWORK-------
----THIS ONLY WORKS FOR ACYCLIC NETWORK------
Input are {'trastuzumab', 'pertuzumab', 'HRG', 'erlotinib', 'EGF'}
Ordinary nodes are 
{'pertuzumab', 'PKCa', 'HRG', 'AKT', 'trastuzumab', 'erlotinib', 'EGF', 'PDK1', 'p70S6K', 'ERBB3', 'ERBB1', 'mTOR', 'ERBB2', 'ERK1_2', 'MEK1_2', 'PLCg'}
Extranodes added after removing cycles are 
['PKCa_to_PKCa', 'AKT_to_AKT', 'PDK1_to_PDK1', 'p70S6K_to_p70S6K', 'ERBB3_to_ERBB3', 'ERBB1_to_ERBB1', 'mTOR_to_mTOR', 'mTOR_to_AKT', 'ERBB2_to_ERBB2', 'ERK1_2_to_ERK1_2', 'MEK1_2_to_MEK1_2', 'PLCg_to_PLCg', 'PLCg_to_ERBB1']
binary.html
----Simulate binary network----
INPUT NAMES LIST:
['EGF', 'HRG', 'erlotinib', 'pertuzumab', 'trastuzumab']
----Generate table from output----
-----Calculated value of input nodes-----
EGF                  			 KO:        0.3 | KI:       -1.2
HRG                  			 KO:        0.3 | KI:       -1.2
erlotinib            			 KO:       -0.7 | KI:        0.8
pertuzumab           			 KO:       -0.7 | KI:        0.8
trastuzumab          			 KO:        0.0 | KI:        0.0
=======PROPAGATE FOR OUTPUT p70S6K=======
----Master diamonds-----
{'AKT': '_XTR_22_', 'ERBB3': '_XTR_23_', 'PDK1': '_XTR_23_', '_XTR_3_': '_XTR_23_', 'ERBB1': '_XTR_23_', '_XTR_1_': '_XTR_23_', 'ERBB2': '_XTR_23_'}


--------PROPAGATION WITH CYCLIC NETWORK--------
IN CYCLIC NETWORK: COMPARE ROWS PROPAGTED TO INPUT NODES AND BASELINE TO ESTIMATE ERROR
AVE_CORRECT_ROWS_INPUT: 0.9
=========================
PROPAGATED VALUES:
AKT                  			 KO:        0.0 | KI:       -5.2
EGF                  			 KO:        0.3 | KI:       -1.2
ERBB1                			 KO:        0.0 | KI:       -5.2
ERBB2                			 KO:        0.0 | KI:       -5.2
ERBB3                			 KO:        0.0 | KI:       -5.2
ERK1_2               			 KO:        0.0 | KI:       -5.2
HRG                  			 KO:        0.3 | KI:       -1.2
MEK1_2               			 KO:        0.0 | KI:       -5.2
PDK1                 			 KO:        0.0 | KI:       -5.2
PLCg                 			 KO:        0.0 | KI:       -1.2
erlotinib            			 KO:       -0.7 | KI:        0.8
mTOR                 			 KO:        0.0 | KI:       -5.2
p70S6K               			 KO:        0.8 | KI:       -5.2
pertuzumab           			 KO:       -0.7 | KI:        0.8
trastuzumab          			 KO:        0.0 | KI:        0.0
KO RANKING OF NODES:
1	p70S6K
2	ERK1_2, mTOR, AKT, PDK1, ERBB3, MEK1_2
	ERBB1, ERBB2, PLCg
=======
KI RANKING OF NODES:
1	p70S6K, ERK1_2, mTOR, AKT, PDK1, ERBB3
	MEK1_2, ERBB1, ERBB2
2	HRG, EGF, PLCg
3	erlotinib, pertuzumab
4	trastuzumab
=======
NUMBER OF NODES: 16
NUMBER OF INPUTS: 5
NUMBER OF EDGES: 41
TIME process heading: 0.00232696533203125
TIME simulate original network: 0.021429061889648438
TIME perform original analysis process: 0.49016809463500977
TIME perform propagation: 0.5810420513153076
There are 1 unreachable nodes, they are:
{'PKCa'}
ERBB3                - Correct: KO:        0.3 | KI :       -5.2 - Incorrect KO:        0.0 | KI:       -5.2
ERBB1                - Correct: KO:        0.3 | KI :       -5.2 - Incorrect KO:        0.0 | KI:       -5.2
AKT
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

EGF
Lack      0: []
Extra     0: []
Real      4: [0, 1, 16, 17]
Prop      4: [0, 1, 16, 17]

ERBB1
Lack      2: [16, 17]
Extra     0: []
Real     28: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

ERBB2
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

ERBB3
Lack      2: [8, 9]
Extra     0: []
Real     28: [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

ERK1_2
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

HRG
Lack      0: []
Extra     0: []
Real      4: [0, 1, 8, 9]
Prop      4: [0, 1, 8, 9]

MEK1_2
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

PDK1
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

PKCa
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

PLCg
Lack      0: []
Extra     0: []
Real      2: [0, 1]
Prop      2: [0, 1]

erlotinib
Lack      0: []
Extra     0: []
Real     12: [8, 9, 12, 13, 16, 17, 20, 21, 24, 25, 28, 29]
Prop     12: [8, 9, 12, 13, 16, 17, 20, 21, 24, 25, 28, 29]

mTOR
Lack      0: []
Extra     0: []
Real     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]
Prop     26: [0, 1, 2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31]

pertuzumab
Lack      0: []
Extra     0: []
Real     12: [8, 9, 10, 11, 16, 17, 18, 19, 24, 25, 26, 27]
Prop     12: [8, 9, 10, 11, 16, 17, 18, 19, 24, 25, 26, 27]

trastuzumab
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

-----KO RANKING COMPARISON-----
1	erlotinib, pertuzumab
2	HRG, EGF
3	ERK1_2, mTOR, AKT, PDK1, ERBB3, MEK1_2
	ERBB1, ERBB2, PLCg, trastuzumab, PKCa
REFERENCE:
1	pertuzumab, erlotinib
2	HRG, EGF, ERBB3, ERBB1
3	trastuzumab, PKCa, AKT, PDK1, mTOR, ERBB2
	ERK1_2, MEK1_2, PLCg
=======
-----KI RANKING COMPARISON-----
1	ERK1_2, mTOR, AKT, PDK1, ERBB3, MEK1_2
	ERBB1, ERBB2
2	HRG, EGF, PLCg
3	erlotinib, pertuzumab
4	trastuzumab, PKCa
REFERENCE:
1	AKT, PDK1, ERBB3, ERBB1, mTOR, ERBB2
	ERK1_2, MEK1_2
2	HRG, EGF, PLCg
3	pertuzumab, erlotinib
4	trastuzumab, PKCa
============
Relative_RMSE_KO_is  0.009128709291752768
Relative_RMSE_KI_is  0.0
NDCG_KO_is  0.9739
NDCG_KI_is  1.0

Ranking Comparison
==================
Metric                                   KO           KI
----------------------------------------------------------
n_common                             15.000       15.000
Kendall tau-b                         0.807        1.000
Spearman rho                          0.887        1.000
Mean abs rank diff                    0.133        0.000
----------------------------------------------------------

Top-r Overlap:
  Top-10 Jaccard                   1.000        1.000
         Precision@10                1.000        1.000
         Recall@10                   1.000        1.000
  Top-20 Jaccard                   1.000        1.000
         Precision@20                1.000        1.000
         Recall@20                   1.000        1.000
----------------------------------------------------------

Top-group Overlap:
  Top-1  groups Jaccard            1.000        1.000
  Top-2  groups Jaccard            0.667        1.000
  Top-3  groups Jaccard            1.000        1.000
==========================================================
AVERAGE_CORRECT_ROWS_ALL_NODES:  0.9917
-----------TOTAL RUNNING TIME---------------
1.2530913329683244
